Maglangit, Gerlyn C.
HRN: 23-47-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2023
CEFUROXIME 500MG (TAB)
08/12/2023
08/19/2023
PO
500mg
BID
UTI
Checking Final Appropriateness
08/12/2023
CEFUROXIME 500MG (TAB)
08/12/2023
08/19/2023
PO
500mg
BID
UTI
Checking Final Appropriateness